Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1700786

	registered interest
	date	15/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what plans they have to prioritise research into variation of the prevalence of prostate cancer among different ethnic groups.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL3809
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The Department welcomes the recently announced TRANSFORM trial which aims to save thousands of men each year by finding the best way to screen for prostate cancer across all ethnic groups. It will be spread across the United Kingdom, although final decisions on specific locations are yet to be taken. Men will be invited to participate via their general practices. This study, led by Prostate Cancer UK and supported by the Government among others, will also aim to address some of the inequalities that exist in prostate cancer diagnosis today by ensuring that one in ten of the trial participants will be black men, who are three times overrepresented compared to the population of men aged between 45 and 75 years old as based on 2021 census data.</p><p> </p><p>More broadly, the National Institute for Health and Care Research (NIHR) funds research in response to proposals received from scientists and commissioned calls rather than allocating funding to specific disease areas. It welcomes funding applications for research into any aspect of human health, including prostate cancer. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>In addition, to raise awareness of prostate cancer in this group, Leicester’s Centre for BME Health has developed a toolkit in partnership with the NIHR with guidance on how to start conversations about prostate cancer and overcome barriers to diagnosis.</p> answering member printed Lord Markham question first answered 17/04/2024 16:29:23 answering member 4948 label Biography information for Lord Markham
	tabling member	4308 label Biography information for The Lord Bishop of St Albans

1699274

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Physician Associates
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 25 March (HL2978), why they have specified how physician associates (PAs) are to be used, specifically with undifferentiated patients, rather than allowing GP practices to make their own decisions about the use of PAs.
	tabling member printed	Baroness Bennett of Manor Castle
	uin	HL3652
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>Physician Associates (PAs) work within a defined scope of practice and limits of competence. NHS England has provided recent guidance on the use of PAs in general practice (GP) teams. As set out in the Network Contract Directed Enhanced Service, PAs should be adequately supervised by a GP when providing care for undifferentiated patients.</p><p>In terms of employment choices, GPs are self-employed contractors to the National Health Service, and it is largely up to employers to determine how best to staff their primary care network or GP, to best meet the needs of their population.</p> answering member printed Lord Markham question first answered 05/04/2024 13:32:33 answering member 4948 label Biography information for Lord Markham
	tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1699315

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made, in each of the past five years, of the economic costs of the effects of post-operative cancer treatments.
	tabling member printed	Lord Wills
	uin	HL3712
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The Department is working jointly with NHS England and Cancer Alliances to ensure every person receives personalised care and support from cancer diagnosis onwards, including post-treatment. As outlined in the NHS Long Term Plan for cancer, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support. After treatment, the person will move to a follow-up pathway that suits their needs, and ensures they can get rapid access to clinical support, where they are worried that their cancer may have recurred.</p><p>Post-operative cancer treatments encompass a wide variety of care, depending on the type and stage of cancer, the treatment the patient has had, and the patient’s needs. Follow-up care often includes regular check-ups, blood tests, scans, and procedures. It may also involve further treatments to deal with late and long-term side effects, including chemotherapy or radiotherapy to reduce the risk of cancer coming back. These highly individualised treatments have varying economic costs.</p> answering member printed Lord Markham question first answered 05/04/2024 13:26:44 answering member 4948 label Biography information for Lord Markham
	tabling member	260 label Biography information for Lord Wills

1699316

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Equipment: Storage
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 9 February (HL2216), why the information mentioned in the Answer on government expenditure is commercially sensitive.
	tabling member printed	Baroness Wolf of Dulwich
	uin	HL3713
	answer	answer is ministerial correction date of answer 09/04/2024 answer text <p>At the time of answering, the Department was engaged in commercial negotiations with NHS Supply Chain and their sub-contractors, relating to ongoing storage requirements for the COVID Strategic Intensive Care Unit. In December 2023, the average per pallet per week cost for equipment in the COVID Strategic Intensive Care Unit was £5.52.</p><p>The Department currently makes payments to NHS Supply Chain in relation to storage of personal protective equipment (PPE). At end of December 2023 there were 492,259 pallets, or 5.1 billion items, of COVID-19 PPE remining in storage. This includes both business as usual and excess stock.</p> answering member printed Lord Markham question first answered 09/04/2024 13:31:41 answering member 4948 label Biography information for Lord Markham
	tabling member	4347 label Biography information for Baroness Wolf of Dulwich

1699327

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Population
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the impact on the UK of the global decline in fertility rates.
	tabling member printed	Lord Farmer
	uin	HL3671
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>No such assessment has been made.</p> answering member printed Lord Markham question first answered 10/04/2024 12:43:43 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699328

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Birth Rate
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the impact of the Abortion Act 1967 on UK birth rates.
	tabling member printed	Lord Farmer
	uin	HL3672
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>No assessment has been made of the impact of the Abortion Act 1967 on United Kingdom birth rates. Parliament decided the circumstances under which abortion can legally be undertaken. Under the act, women have access to safe, legal, regulated abortion services.</p> answering member printed Lord Markham question first answered 10/04/2024 11:07:17 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699329

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health: Boys
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what action they are taking to help the mental health of boys who were impacted by the lockdown restrictions.
	tabling member printed	Lord Farmer
	uin	HL3673
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>We want to ensure that all children and young people get the mental health support they need, including boys.</p><p>By the end of 2023/24 the overall spending on mental health has increased by more than £4.7 billion in cash terms since 2018/19 (before the COVID-19 lockdown restrictions were introduced).</p><p>There are now around 400 mental health support teams in place across England, covering 3.4 million children or around 35% of pupils in schools and colleges. We estimate this will increase to 44% by April 2024 and we are working to increase this coverage to 50% of pupils by March 2025.</p><p>There are also currently around 65 locally funded early support hubs in England. These hubs are open to those aged 11 to 25 years old and, importantly, they are for anyone who may not meet the threshold to receive National Health Service support. Following a competitive commercial process from hubs across the country, the government is now providing up to £8 million to 24 existing hubs to provide even more support. This means children and young people, including boys, who are experiencing feelings of anxiety or stress will have a physical space to go to in their community when their problems first emerge, without the need for a referral.</p> answering member printed Lord Markham question first answered 10/04/2024 11:07:05 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699223

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gender Plus
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government whether they have reviewed the decision of the Care Quality Commission to approve the registration of Gender Plus Healthcare in east London, which runs the private Gender Plus hormone clinic set up by former Tavistock Gender Identity Development Service specialist Dr Aidan Kelly, and which can refer patients aged 16 to 18 for cross-sex hormone treatment.
	tabling member printed	Baroness Hayter of Kentish Town
	uin	HL3613
	answer	answer is ministerial correction date of answer 11/04/2024 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and social care in England, and one of its statutory responsibilities is to assess and register providers of regulated activity, as set out in schedule one of the Health and Social Care Act 2008. Gender Plus Healthcare is a United Kingdom based private gender clinic offering a range of treatment options, including hormone treatment, for those aged 16 years old and over.</p><p>In January 2024 the CQC approved Gender Plus Healthcare’s registration to carry out the regulated activity of treatment of disease, disorder, or injury, with the provider having met the CQC’s requirements for registration. The registration by the CQC was on the condition that the provider must not carry out the regulated activity of treatment of disease, disorder, or injury, on those under the age of 16 years old, at any location.</p> answering member printed Lord Markham question first answered 11/04/2024 10:53:29 answering member 4948 label Biography information for Lord Markham
	tabling member	4159 label Biography information for Baroness Hayter of Kentish Town

1699224

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gender Dysphoria: Children and Young People
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government why the National Institute for Health and Care Excellence 2020 evidence review of gender-affirming hormones for children and adolescents with gender dysphoria was not referenced in the list of resources which informed NHS England’s decision on the prescription of gender-affirming hormones for children and adolescents.
	tabling member printed	Baroness Hayter of Kentish Town
	uin	HL3614
	answer	answer is ministerial correction date of answer 09/04/2024 answer text <p>NHS England has not adopted a new policy for gender-affirming hormones. NHS England made a consequential amendment to their gender-affirming hormones policy to bring it into alignment with the new puberty suppressing hormones policy. This planned update was set out in the puberty suppressing hormones policy consultation documents.</p><p>NHS England has put additional safeguards on the use of cross-sex hormones, for instance that any prescription to young people aged between 16 and 18 years old must be approved by a national multi-disciplinary team.</p><p>NHS England will continue to review the gender affirming hormone policy in line with the latest clinical advice, and will take note of recommendations set out in the Cass Review, once the final report has been delivered.</p> answering member printed Lord Markham question first answered 09/04/2024 13:42:02 answering member 4948 label Biography information for Lord Markham
	tabling member	4159 label Biography information for Baroness Hayter of Kentish Town

1699226

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Procurement
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what recent assessment they have made regarding the potential for insourcing to tackle NHS waiting lists.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL3616
	answer	answer is ministerial correction date of answer 08/04/2024 answer text <p>Independent sector providers have a significant role to play in supporting the National Health Service as trusted partners, to recover elective services. The Elective Recovery Taskforce was launched in 2022 to consider how capacity across the system could be best utilised, including how insourcing could be used to meet the ambitions on long waits. The taskforce concluded its work by publishing an implementation plan in August 2023, which sets out a series of actions that have either been delivered, or will be delivered, over the coming months.</p><p>Local systems are best placed to consider how to utilise insourcing as part of their delivery plans, in a way which works for their areas. To support the system, NHS England produced <em>Guidance for trusts on the use of insourcing</em> and NHS Shared Business Services produced the <em>Insourcing of Clinical Services Framework Agreement</em>.</p> answering member printed Lord Markham grouped question UIN HL3587 HL3617 question first answered 08/04/2024 11:17:10 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath